Monitoring changes in malaria epidemiology and effectiveness of interventions in Ethiopia and Uganda: Beyond Garki Project baseline survey

Malaria Journal
Tarekegn A AbekuSylvia R Meek

Abstract

Scale-up of malaria interventions seems to have contributed to a decline in the disease but other factors may also have had some role. Understanding changes in transmission and determinant factors will help to adapt control strategies accordingly. Four sites in Ethiopia and Uganda were set up to monitor epidemiological changes and effectiveness of interventions over time. Here, results of a survey during the peak transmission season of 2012 are reported, which will be used as baseline for subsequent surveys and may support adaptation of control strategies. Data on malariometric and entomological variables, socio-economic status (SES) and control coverage were collected. Malaria prevalence varied from 1.4 % in Guba (Ethiopia) to 9.9 % in Butemba (Uganda). The most dominant species was Plasmodium vivax in Ethiopia and Plasmodium falciparum in Uganda. The majority of human-vector contact occurred indoors in Uganda, ranging from 83 % (Anopheles funestus sensu lato) to 93 % (Anopheles gambiae s.l.), which is an important factor for the effectiveness of insecticide-treated nets (ITNs) or indoor residual spraying (IRS). High kdr-L1014S (resistance genotype) frequency was observed in A. gambiae sensu stricto in Uganda. Too few mosquito...Continue Reading

References

Jan 1, 1992·International Journal of Health Services : Planning, Administration, Evaluation·O Gish
Sep 24, 1999·Transactions of the Royal Society of Tropical Medicine and Hygiene·A H KilianG Kabagambe
Nov 1, 1961·The American Journal of Tropical Medicine and Hygiene·R E FONTAINEJ S PRINCE
Mar 29, 2005·Proceedings of the National Academy of Sciences of the United States of America·C J DrakeleyE M Riley
Nov 9, 2007·Trends in Parasitology·Patrick CorranChris Drakeley
Oct 2, 2008·Malaria Journal·Patrick H CorranEleanor Riley
Mar 30, 2010·The American Journal of Tropical Medicine and Hygiene·Katrijn VerhaeghenMarc Coosemans
Apr 21, 2010·PLoS Medicine·Julie Knoll RajaratnamChristopher J L Murray
Jan 1, 2010·Malaria Research and Treatment·Fatuma NamusokeFlorence Mirembe
Mar 6, 2013·The American Journal of Tropical Medicine and Hygiene·Laura C SteinhardtScott Filler
Jan 1, 2012·International Quarterly of Community Health Education
Sep 21, 2013·Journal of Medical Microbiology·Joel C Mouatcho, J P Dean Goldring
Sep 26, 2013·The American Journal of Tropical Medicine and Hygiene·Adam BennettAbdisalan M Noor

❮ Previous
Next ❯

Citations

Apr 8, 2018·Malaria Journal·Habtie TesfaAyalew Jejaw Zeleke
Oct 28, 2018·Malaria Journal·Endalew ZemeneDelenasaw Yewhalaw
Mar 31, 2019·BMC Research Notes·Tsegaye Shamebo, Beyene Petros
Jul 17, 2019·Malaria Journal·Sileshi BelewBart De Spiegeleer
Jul 25, 2019·Tropical Diseases, Travel Medicine and Vaccines·Tadele GirumMisgun Shewangizaw
Sep 19, 2021·Malaria Journal·Mihretu TarekegnYitbarek Wolde-Hawariat

❮ Previous
Next ❯

Methods Mentioned

BETA
enzyme-linked immunosorbent assay

Software Mentioned

EpiData
Stata
Excel

Related Concepts

Related Feeds

Cachexia & Brown Fat

Cachexia is a condition associated with progressive weight loss due to severe illness. In cancer patients, it is proposed to occur as a result of tumor-induced energy wasting. Several proteins have been implicated in browning and depletion of white adipose tissue. Here is the latest research on cachexia and brown fat.

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Absence Epilepsy

Absence epilepsy is a common seizure disorder in children which can produce chronic psychosocial sequelae. Discover the latest research on absence epilepsies here.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Cardiac Cachexia

Cardiac cachexia is a syndrome associated with the progressive loss of muscle and fat mass. It most commonly affects patients with heart failure and can significantly decrease the quality of life and survival in these patients. Here is the latest research on cardiac cachexia.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.